(Q46765808)

English

Induction of HSP70 expression and recruitment of HSC70 and HSP70 in the nucleus reduce aggregation of a polyalanine expansion mutant of PABPN1 in HeLa cells

scientific article published on 20 October 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16239242

Induction of HSP70 expression and recruitment of HSC70 and HSP70 in the nucleus reduce aggregation of a polyalanine expansion mutant of PABPN1 in HeLa cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16239242

author name string

Qishan Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16239242

Dick D Mosser

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16239242

Jnanankur Bag

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16239242

publication date

20 October 2005

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16239242

Human Molecular Genetics

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16239242

14

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16239242

23

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16239242

3673-3684

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16239242

A novel poly(A)-binding protein acts as a specificity factor in the second phase of messenger RNA polyadenylation

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI395

21 January 2018

Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI395

21 January 2018

Triplet repeat expansion in neuromuscular disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI395

21 January 2018

Mammalian, yeast, bacterial, and chemical chaperones reduce aggregate formation and death in a cell model of oculopharyngeal muscular dystrophy

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI395

21 January 2018

Pharmacological modulation of heat shock factor 1 by antiinflammatory drugs results in protection against stress-induced cellular damage

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI395

21 January 2018

The product of an oculopharyngeal muscular dystrophy gene, poly(A)-binding protein 2, interacts with SKIP and stimulates muscle-specific gene expression

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI395

21 January 2018

Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI395

21 January 2018

Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI395

21 January 2018

Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI395

21 January 2018

Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI395

21 January 2018

Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI395

21 January 2018

Molecular chaperones and the stress of oncogenesis

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI395

21 January 2018

Metal chelator decreases Alzheimer beta-amyloid plaques

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI395

21 January 2018

Clioquinol, a drug for Alzheimer's disease specifically interfering with brain metal metabolism: structural characterization of its zinc(II) and copper(II) complexes

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI395

21 January 2018

Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI395

21 January 2018

Immunoblotting and dot immunobinding — Current status and outlook

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDI395

21 January 2018

Identifiers

10.1093/HMG/DDI395

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16239242

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16239242

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46765808&oldid=2130325940"